News
Feed
Events
Feed
News
+ Events
Feed

Neovacs S.A.

  • ISIN FR0004032746
  • Land Frankreich

Aktuelle News

7 Dezember 2016

07:00 Corporate EN

Neovacs S.A.

Corporate
EN

Neovacs obtains FDA ‘Fast Track’ designation for IFNα Kinoid in Lupus (SLE)

23 November 2016

17:45 Corporate EN

Neovacs S.A.

Corporate
EN

Neovacs signs production partnership with 3P Biopharmaceuticals, a leading GMP producer of biological drugs

15 November 2016

07:00 Corporate EN

Neovacs S.A.

Corporate
EN

NEOVACS ACQUIRES INTERFERON ALPHA MANUFACTURING TECHNOLOGY FROM AMEGABIOTECH

7 November 2016

07:00 Corporate EN

Neovacs S.A.

Corporate
EN

Neovacs enrolls the first U.S. Patient in Phase IIb study of IFNa Kinoid for treatment of Systemic Lupus Erythematosus (SLE)

3 November 2016

08:00 Corporate EN

Neovacs S.A.

Corporate
EN

Neovacs to attend Jefferies 2016 London Healthcare Conference November 16 & 17, 2016

12 Oktober 2016

11:05 Corporate EN

Neovacs S.A.

Corporate
EN

Neovacs S.A. signs a cooperation agreement with the Department Immunology of Diabetes at the reputed Hospital Cochin in Paris

30 September 2016

17:45 Corporate EN

Neovacs S.A.

Corporate
EN

Neovacs S.A.: Half-year results 2016 and update on operational development

30 August 2016

08:00 Corporate EN

Neovacs S.A.

Corporate
EN

Neovacs to present at two major Investor Conferences

19 Juli 2016

08:00 Corporate EN

Neovacs S.A.

Corporate
EN

Neovacs and Stellar Biotechnologies Announce Launch of Neostell, Joint Venture to Manufacture Kinoids

30 Mai 2016

08:00 Corporate EN

Neovacs S.A.

Corporate
EN

Neovacs to Present at Bio International Convention 2016

17 Mai 2016

08:30 Corporate EN

Neovacs S.A.

Corporate
EN

Neovacs to attend ChinaBio(R) Event May 18 & 19, 2016

12 Mai 2016

08:00 Corporate EN

Neovacs S.A.

Corporate
EN

Neovacs and Stellar Biotechnologies sign a joint venture agreement to create Neostell SAS

28 April 2016

17:40 Corporate EN

Neovacs S.A.

Corporate
EN

Neovacs obtains FDA approval to extend its Phase IIb clinical trial in Lupus to United States

14 April 2016

09:45 Corporate EN

Neovacs S.A.

Corporate
EN

NEOVACS OBTAINS SOUTH KOREA HEALTH AUTHORITY APPROVAL FOR IND APPLICATION WITH INFα KINOID IN LUPUS

7 März 2016

08:00 Corporate EN

Neovacs S.A.

Corporate
EN

NEOVACS REPORTS FULL YEAR 2015 FINANCIAL RESULTS

29 Januar 2016

08:00 Corporate EN

Neovacs S.A.

Corporate
EN

Neovacs S.A.: 2016 Financial Calendar

21 Januar 2016

08:00 Corporate EN

Neovacs S.A.

Corporate
EN

Neovacs associates Stellar Biotechnologies in its industrial Project

6 Januar 2016

08:00 Corporate EN

Neovacs S.A.

Corporate
EN

Neovacs secures EUR5 million from the public funding program «Investments for the Future» to support clinical and industrial development for the therapeutic vaccine INFα Kinoïd

15 Dezember 2015

08:00 Corporate EN

Neovacs S.A.

Corporate
EN

Neovacs signs a strategic partnering agreement with the Korean company CKD Pharmaceutical Corp.

1 Dezember 2015

08:00 Corporate EN

Neovacs S.A.

Corporate
EN

Neovacs announces its engagement in the field of immunotherapy in cancer, following the recommendation of its Scientific Advisory Board which met in New York on the 17th of November

28 Oktober 2015

08:00 Corporate EN

Neovacs S.A.

Corporate
EN

NEOVACS ANNOUNCES ITS PARTICIPATION IN UPCOMING INVESTOR CONFERENCES

2 Oktober 2015

08:00 Corporate EN

Neovacs S.A.

Corporate
EN

NEOVACS REPORTS FIRST-HALF 2015 FINANCIAL RESULTS

24 September 2015

08:00 Corporate EN

Neovacs S.A.

Corporate
EN

NEOVACS INITIATES PHASE IIb TRIAL OF IFNα-KINOID FOR THE TREATMENT OF LUPUS

9 September 2015

08:00 Corporate EN

Neovacs S.A.

Corporate
EN

NEOVACS CONFIRMS POTENT AND LONG-LASTING BIOLOGICAL ACTIVITY OF IFNα-KINOID 4 YEARS AFTER PATIENT DOSING IN PHASE I/IIa TRIAL

1 September 2015

08:00 Corporate EN

Neovacs S.A.

Corporate
EN

NEOVACS RECEIVES FIRST REGULATORY APPROVALS FOR A PHASE IIb TRIAL OF IFNα-KINOID IN LUPUS

2 Juli 2015

08:00 Corporate EN

Neovacs S.A.

Corporate
EN

NEOVACS ANNOUNCES CLOSING OF 7.5M EURO CAPITAL INCREASE WITH U.S. INSTITUTIONAL INVESTORS

26 Juni 2015

08:00 Corporate EN

Neovacs S.A.

Corporate
EN

NEOVACS RAISES 7.5 MILLION EUROS IN CAPITAL INCREASE WITH U.S. INSTITUTIONAL INVESTORS

16 Juni 2015

08:00 Corporate EN

Neovacs S.A.

Corporate
EN

NEOVACS INITIATES CLINICAL PROGRAM IN DERMATOMYOSITIS

3 Juni 2015

08:00 Corporate EN

Neovacs S.A.

Corporate
EN

NEOVACS TO PRESENT AT 2015 BIO INTERNATIONAL CONVENTION

14 April 2015

08:00 Corporate EN

Neovacs S.A.

Corporate
EN

NEOVACS TO PRESENT AT CHINA BIO PARTNERING FORUM

Anstehende Events

Keine Events gefunden